Specialists from Belarus and Russia are actively collaborating on this matter. The Belarusian side has already determined the healthcare facilities where the trials will be done. Now some technical issues are being negotiated taking into account national and international requirements.
The categories and the number of patients are being determined. “According to preliminary information provided by the Russian side, there are plans to begin clinical trials in September this year,” the press service noted.
In addition, at the suggestion of the Russian side, Belarusian specialists are considering a possibility to make the vaccine with varying degrees of localization at Belarus' pharmaceutical companies.
